Elwha LLC
Records under this name other than the patents Elwha LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,683,365 | Tubular Nanostructure Targeted to Cell Membrane now held by Enterprise Science Fund, LLC In force · Medium confidence | In force | Medium confidence | |
| US 8,969,848 | Materials and Configurations of a Field Emission Device now held by Modern Hydrogen, Inc. In force · High confidence | In force | High confidence | |
| US 8,930,714 | Encrypted memory now held by RPX Corporation In force · Medium confidence | In force | Medium confidence | |
| US 9,646,798 | Electronic Device Graphene Grid now held by Modern Hydrogen, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 8,941,305 | Field Emission Device now held by Modern Hydrogen, Inc. In force · Medium confidence | In force | Medium confidence | |
| US 9,245,254 | Enhanced Voice Conferencing with History, Language Translation and Identification now held by Microsoft Technology Licensing, LLC In force · High confidence | In force | High confidence | |
| US 8,962,315 | Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including at Least One Endogenous Gene Expressing at Least One Endogenous Membrane Immunoglobulin Reactive to a First Antigen and Including at Least One Exogenously Incorporated Nucleic Acid Expressing at Least One Exogenous Secreted Immunoglobulin Reactive to a Second Antigen now held by The Invention Science Fund II, LLC In force · Medium confidence | In force | Medium confidence | |
| US 9,512,213 | Compositions and Methods Including Recombinant B Lymphocyte Cell Line Including an Exogenously Incorporated Nucleic Acid Expressing an Exogenous Membrane Immunoglobulin Reactive to a First Antigen and Including an Endogenous Gene Expressing an Endogenous Secreted Immunoglobulin Reactive to a Second Antigen now held by The Invention Science Fund II, LLC In force · High confidence | In force | High confidence | |
| US 10,875,525 | Ability Enhancement now held by Microsoft Technology Licensing, LLC In force · High confidence | In force | High confidence | |
| US 10,745,468 | Compositions and Methods for Modified B Cells Expressing Reassigned Biological Agents now held by The Invention Science Fund II, LLC In force · High confidence | In force | High confidence |